关注
Daniel Wiseman
Daniel Wiseman
未知所在单位机构
在 manchester.ac.uk 的电子邮件经过验证
标题
引用次数
引用次数
年份
Donor cell leukemia: a review
DH Wiseman
Biology of Blood and Marrow Transplantation 17 (6), 771-789, 2011
2062011
Mutations in TRNT1 cause congenital sideroblastic anemia with immunodeficiency, fevers, and developmental delay (SIFD)
PK Chakraborty, K Schmitz-Abe, EK Kennedy, H Mamady, T Naas, ...
Blood, The Journal of the American Society of Hematology 124 (18), 2867-2871, 2014
1942014
Coordinated alterations in RNA splicing and epigenetic regulation drive leukaemogenesis
A Yoshimi, KT Lin, DH Wiseman, MA Rahman, A Pastore, B Wang, ...
Nature 574 (7777), 273-277, 2019
1842019
Enhancer activation by pharmacologic displacement of LSD1 from GFI1 induces differentiation in acute myeloid leukemia
A Maiques-Diaz, GJ Spencer, JT Lynch, F Ciceri, EL Williams, ...
Cell reports 22 (13), 3641-3659, 2018
1802018
Reversible inhibitors of LSD1 as therapeutic agents in acute myeloid leukemia: clinical significance and progress to date
DP Mould, AE McGonagle, DH Wiseman, EL Williams, AM Jordan
Medicinal research reviews 35 (3), 586-618, 2015
1702015
A novel syndrome of congenital sideroblastic anemia, B-cell immunodeficiency, periodic fevers, and developmental delay (SIFD)
DH Wiseman, A May, S Jolles, P Connor, C Powell, MM Heeney, ...
Blood, The Journal of the American Society of Hematology 122 (1), 112-123, 2013
1152013
SF3B1 mutations induce R-loop accumulation and DNA damage in MDS and leukemia cells with therapeutic implications
S Singh, D Ahmed, H Dolatshad, D Tatwavedi, U Schulze, A Sanchi, ...
Leukemia 34 (9), 2525-2530, 2020
792020
Frequent derepression of the mesenchymal transcription factor gene FOXC1 in acute myeloid leukemia
TDD Somerville, DH Wiseman, GJ Spencer, X Huang, JT Lynch, ...
Cancer cell 28 (3), 329-342, 2015
682015
CD86 expression as a surrogate cellular biomarker for pharmacological inhibition of the histone demethylase lysine-specific demethylase 1
JT Lynch, MJ Cockerill, JR Hitchin, DH Wiseman, TCP Somervaille
Analytical biochemistry 442 (1), 104-106, 2013
622013
The variety of leukemic stem cells in myeloid malignancy
DH Wiseman, BF Greystoke, TCP Somervaille
Oncogene 33 (24), 3091-3098, 2014
612014
Discovery and optimization of allosteric inhibitors of mutant isocitrate dehydrogenase 1 (R132H IDH1) displaying activity in human acute myeloid leukemia cells
S Jones, J Ahmet, K Ayton, M Ball, M Cockerill, E Fairweather, N Hamilton, ...
Journal of Medicinal Chemistry 59 (24), 11120-11137, 2016
532016
Single-cell genomics reveals the genetic and molecular bases for escape from mutational epistasis in myeloid neoplasms
J Taylor, X Mi, K North, M Binder, A Penson, T Lasho, K Knorr, ...
Blood, The Journal of the American Society of Hematology 136 (13), 1477-1486, 2020
502020
Management of mucopolysaccharidosis type IH (Hurler’s syndrome) presenting in infancy with severe dilated cardiomyopathy: a single institution’s experience
DH Wiseman, J Mercer, K Tylee, N Malaiya, DK Bonney, SA Jones, ...
Journal of inherited metabolic disease 36, 263-270, 2013
412013
Divergent clonal evolution of blastic plasmacytoid dendritic cell neoplasm and chronic myelomonocytic leukemia from a shared TET2-mutated origin
K Batta, HM Bossenbroek, N Pemmaraju, DP Wilks, R Chasty, M Dennis, ...
Leukemia 35 (11), 3299-3303, 2021
262021
The dynamic interface between the bone marrow vascular niche and hematopoietic stem cells in myeloid malignancy
L Mosteo, J Storer, K Batta, EJ Searle, D Duarte, DH Wiseman
Frontiers in cell and developmental biology 9, 635189, 2021
232021
Guidelines for the management of adult myelodysplastic syndromes
SB Killick, W Ingram, D Culligan, H Enright, J Kell, EM Payne, ...
British journal of haematology 194 (2), 267-281, 2021
222021
Chronic myelomonocytic leukaemia stem cell transcriptomes anticipate disease morphology and outcome
DH Wiseman, SM Baker, AV Dongre, K Gurashi, JA Storer, ...
EBioMedicine 58, 2020
202020
Loss of TET2 in human hematopoietic stem cells alters the development and function of neutrophils
HH Encabo, IV Aramburu, M Garcia-Albornoz, M Piganeau, H Wood, ...
Cell stem cell 30 (6), 781-799. e9, 2023
172023
Enhancer recruitment of transcription repressors RUNX1 and TLE3 by mis-expressed FOXC1 blocks differentiation in acute myeloid leukemia
F Simeoni, I Romero-Camarero, F Camera, FMR Amaral, OJ Sinclair, ...
Cell Reports 36 (12), 2021
172021
Frequent reconstitution of IDH2R140Q mutant clonal multilineage hematopoiesis following chemotherapy for acute myeloid leukemia
DH Wiseman, EL Williams, DP Wilks, H Sun Leong, TDD Somerville, ...
Leukemia 30 (9), 1946-1950, 2016
172016
系统目前无法执行此操作,请稍后再试。
文章 1–20